Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,747.12
(
0.71%
)
US TECH 100
24,193.40
(
0.74%
)
Dow Jones
47,308.79
(
0.77%
)
Brent Oil
100.18
(
1.91%
)
Bitcoin
73,623.78
(
-1.63%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: jq1234 post# 140288

Monday, 04/16/2012 9:05:41 PM

Monday, April 16, 2012 9:05:41 PM

Post# of 257251

They can't partner EC20 with MRK because they only partner EC145 with MRK. The rest of their folate receptor pipeline will also depend on this test.

So, ECYT will presumably retain all revenues from EC20 in conjunction with EC145 and hopefully any subsequent drugs.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now